SCHEMBL13998202

SCHEMBL13998202

C=C[C@H]1C(O)OC=C2C(=O)OCC[C@]21O

nearest known ligand 0.00

⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL13998189 0.85 LMNA (0.31) —
SCHEMBL13906103 0.85 LMNA (0.31) —
SCHEMBL14010918 0.78 — —
B-D-Galactose SCHEMBL31152475 0.77 STAT3 (0.40) —
SCHEMBL14010716 0.63 — —
SCHEMBL31371996 0.60 STAT3 (0.56) —
SCHEMBL1924154 0.54 LMNA (0.35) —
SCHEMBL12438024 0.53 LMNA (0.52) —
SCHEMBL5078178 0.51 LMNA (0.44) —
SCHEMBL22246759 0.51 — —

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20080319042-A1 Compositions and methods for treatment of liver disease CALECO PHARMA CORP. 2008-12-25 — — US disclosed
Send feedback